BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18774564)

  • 1. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
    Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
    Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
    Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
    Orikaza CM; Morelli VM; Matos MF; Lourenço DM
    Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
    de Bruijne EL; Darwish Murad S; de Maat MP; Tanck MW; Haagsma EB; van Hoek B; Rosendaal FR; Janssen HL; Leebeek FW;
    Thromb Haemost; 2007 Feb; 97(2):181-5. PubMed ID: 17264944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss in Japanese women.
    Saijo Y; Sata F; Yamada H; Kondo T; Kato EH; Kishi R
    Fertil Steril; 2004 Feb; 81(2):374-8. PubMed ID: 14967376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
    Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
    Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.
    Acosta-Tejeda M; Baptista-González H; Rosenfeld-Mann F; Trueba-Gómez R; García-Latorre E
    Thromb Res; 2011 Oct; 128(4):e39-42. PubMed ID: 21708401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the protein Z intron F G79A gene polymorphism with recurrent pregnancy loss.
    Dossenbach-Glaninger A; van Trotsenburg M; Helmer H; Oberkanins C; Hopmeier P
    Fertil Steril; 2008 Oct; 90(4):1155-60. PubMed ID: 18177644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss.
    Papazoglou D; Galazios G; Papatheodorou K; Liberis V; Papanas N; Maltezos E; Maroulis GB
    Fertil Steril; 2005 Apr; 83(4):959-63. PubMed ID: 15820807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of early recurrent fetal loss and levels of thrombin-activatable fibrinolysis inhibitor.
    Legnani C; Bovara M; Valdrè L; Cosmi B; Caniato A; Palareti G
    Thromb Res; 2012 Aug; 130(2):237-41. PubMed ID: 22032800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
    Franco RF; Fagundes MG; Meijers JC; Reitsma PH; Lourenço D; Morelli V; Maffei FH; Ferrari IC; Piccinato CE; Silva WA; Zago MA
    Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women.
    Kamali-Sarvestani E; Zolghadri J; Gharesi-Fard B; Sarvari J
    J Reprod Immunol; 2005 Apr; 65(2):171-8. PubMed ID: 15811521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion.
    Lee HH; Hong SH; Shin SJ; Ko JJ; Oh D; Kim NK
    Fertil Steril; 2010 Mar; 93(4):1244-7. PubMed ID: 19131057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss.
    Firouzabadi RD; Ghasemi N; Rozbahani MA; Tabibnejad N
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):216-9. PubMed ID: 19432615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss.
    Eller AG; Branch DW; Nelson L; Porter TF; Silver RM
    J Reprod Immunol; 2011 Jan; 88(1):48-52. PubMed ID: 20977975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in tunisian women.
    Zammiti W; Mtiraoui N; Mahjoub T
    Am J Reprod Immunol; 2008 Feb; 59(2):139-45. PubMed ID: 18211539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women.
    Palmirotta R; La Farina F; Ferroni P; Ludovici G; Nigro C; Savonarola A; Raparelli V; Riondino S; Rampini MR; Guadagni F; Basili S
    Reprod Sci; 2010 Jul; 17(7):659-66. PubMed ID: 20388617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.
    Vairaktaris E; Yapijakis C; Nkenke E; Vassiliou S; Vylliotis A; Nixon AM; Derka S; Ragos V; Spyridonidou S; Tsigris C; Neukam FW; Patsouris E
    Am J Hematol; 2007 Nov; 82(11):1010-2. PubMed ID: 17636471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.